NATPARA (PARATHYROID HORMONE) FOR INJECTION
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 13 Jan 2023)
What this means for you
Registered since 26 Jul 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86520266
- Registration number
- 5008838
- Mark type
- Design + words
- Filed
- 30 Jan 2015
- Published for opposition
- 05 May 2015
- Registered
- 26 Jul 2016
- Attorney of record
- Karl M. Zielaznicki, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations including parathyroid hormone for the treatment or prevention of hypoparathyroidism, diseases involving calcium regulation, diseases involving varying levels of calcium in cells and outside cells, endocrine disorders, or bone metabolism disorders
Owner
- TAKEDA PHARMACEUTICALS U.S.A., INC., LEXINGTON, MA, US
- SHIRE-NPS PHARMACEUTICALS, INC., LEXINGTON, MA, US
- NPS Pharmaceuticals, Inc., Bedminster, NJ, US
- NPS Pharmaceuticals, Inc., Bedminster, NJ, US
- NPS Pharmaceuticals, Inc., Bedminster, NJ, US
Prosecution history
- 26 Jul 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 13 Jan 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 13 Jan 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 13 Jan 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Oct 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 28 Jun 2022 — TEAS SECTION 8 & 15 RECEIVED
- 26 Jul 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 01 Jul 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 01 Jul 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Jul 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 01 Jul 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 01 Jul 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 10 Aug 2016 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 02 Aug 2016 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Aug 2016 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED